Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com
David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2011/06/08 - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation titled “Willie Sutton’s Getaway Car and the Pathogenesis of Lewy Body Diseases” at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23, 2011 in San Francisco, CA

Dr. Goldstein has been at NIH since 1978, tenured in 1984 (NHLBI), and founded and still leads the Clinical Neurocardiology Section in intramural NINDS in 1999. His discoveries include cardiac sympathetic denervation in Parkinson disease, stressor-specific activation of the sympathetic noradrenergic and adrenomedullary hormonal systems, sympathoadrenal imbalance preceding neurocardiogenic syncope, autoimmune autonomic ganglionopathy, and decreased vesicular uptake of neuronal catecholamines in Lewy body diseases. His current research focuses on biomarkers and mechanisms of loss of catecholaminergic neurons in Parkinson disease and related disorders.

Dr. Goldstein will present a conceptual framework for answering four key questions about the pathogenesis of Lewy body diseases. (1) Only a very small percent of neurons are catecholaminergic. What renders them susceptible? (2) All genotypic abnormalities identified so far that cause familial PD have no obvious relationship to catecholamines. How do generalized genetic predispositions lead to relatively specific loss of catecholaminergic neurons? (3) The protein alpha-synuclein is expressed in all neurons, and precipitated alpha-synuclein is a prominent component of Lewy bodies. Why does alpha-synuclein tend to precipitate in the cytosol of catecholaminergic neurons? And (4) Why are PD and DLB diseases of the elderly? The analogy of Willie Sutton’s getaway car provides a basis for new ideas about potential diagnostic, treatment, and preventative strategies in Lewy body diseases.

Other topics to be discussed at the conference include Neuroimaging Techniques for Drug Discovery, Neuropsychiatric Therapeutics, Cognition across Neuropsychiatric Disorders, New Treatments Hiding in Glutamate Synapses, The Role of Epigenetics and Genomics, and Lessons & Success in Clinical Trials.

Also presenting at the Advances in Neuropsychiatric Treatment Conference are prestigious organizations including Abbott, Addex Pharma, Amgen, Johnson & Johnson, National Psychosis Service (UK), Neuronetics, NIDA, NIH, Roche, Stanford, UC San Francisco, University of Michigan, UNC School of Medicine, Weill Cornell Med and other leaders in the neuroscience and psychiatry fields. For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.

Visit  S&A Capital Partner Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today